Scholar Rock Holding buy BMO Capital Markets
Start price
11.10.24
/
50%
€23.60
Target price
11.10.25
€34.71
Performance (%)
13.56%
Price
15.08.25
€26.80
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 13.56%. This prediction currently runs until 11.10.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Scholar Rock Holding | -2.190% | -2.190% |
| iShares Core DAX® | 0.648% | 1.259% |
| iShares Nasdaq 100 | -0.034% | 2.797% |
| iShares Nikkei 225® | 2.445% | 9.854% |
| iShares S&P 500 | 0.492% | 2.570% |
Comments by BMO_Capital_Markets for this prediction
In the thread Scholar Rock Holding diskutieren
Scholar Rock Holding Co. (NASDAQ: SRRK) had its price target raised by analysts at BMO Capital Markets from $34.00 to $38.00. They now have an "outperform" rating on the stock.
Ratings data for SRRK provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Scholar Rock Holding
Scholar Rock Holding
Start price
Target price
Perf. (%)
€29.60
07.08.25
07.08.25
€38.59
07.08.26
07.08.26
-9.46%
15.08.25
15.08.25
Scholar Rock Holding
Start price
Target price
Perf. (%)
€8.80
13.06.24
13.06.24
€28.79
13.06.25
13.06.25
215.91%
14.06.25
14.06.25